BRIM Biotechnology (TPE:6885) Institutional Ownership: 0.09% (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6885 BRIM Biotechnology Inc TPE:6885
42 GF Score
Price NT$20.55
GF Value NT$707.93
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is BRIM Biotechnology Institutional Ownership?

BRIM Biotechnology TPE:6885 +0.98% 42 Institutional Ownership is 0.09% as of Aug. 21, 2026. GuruFocus rates TPE:6885 with a GF Score™ of 42/100 and a GF Value™ of NT$707.93 (Possible Value Trap). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BRIM Biotechnology's institutional ownership is 0.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BRIM Biotechnology's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BRIM Biotechnology's Float Percentage Of Total Shares Outstanding is 0.00%.

BRIM Biotechnology Institutional Ownership Historical Data

* Premium members only.

The historical data trend for BRIM Biotechnology's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BRIM Biotechnology Institutional Ownership Chart

BRIM Biotechnology Historical Data

The historical data trend for BRIM Biotechnology can be seen below:

2025-03-31 2025-04-30 2025-05-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.03 0.03 0.03 0.03 0.05 0.05 0.05 0.05 0.06 0.09
TPE:6885
42GF Score
BRIM Biotechnology Inc TPE:6885
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BRIM Biotechnology Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.09% mean?
BRIM Biotechnology (TPE:6885) has a Institutional Ownership of 0.09% as of Aug. 21, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on BRIM Biotechnology and its competitors.
Is BRIM Biotechnology's Institutional Ownership too high?
BRIM Biotechnology's current Institutional Ownership is 0.09%. Overall, BRIM Biotechnology has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BRIM Biotechnology's Institutional Ownership compare to VRTX and REGN?
BRIM Biotechnology's Institutional Ownership of 0.09% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on BRIM Biotechnology and its competitors. BRIM Biotechnology's current Institutional Ownership is 0.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BRIM Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, BRIM Biotechnology (TPE:6885) is currently considered Possible Value Trap. The stock's GF Value™ is NT$707.93, compared to a current price of NT$20.55 — trading 97.1% below its estimated fair value. The current Institutional Ownership is 0.09%. BRIM Biotechnology's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For BRIM Biotechnology (TPE:6885), the current Institutional Ownership is 0.09% as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BRIM Biotechnology (TPE:6885) Overvalued in 2026?

Based on GuruFocus' analysis, BRIM Biotechnology stock appears to be undervalued. The current stock price of NT$20.55 is trading 97.1% below its estimated GF Value™ of NT$707.93. GuruFocus considers BRIM Biotechnology to be Possible Value Trap.

Key valuation signals for TPE:6885:

  • Institutional Ownership: 0.09%
  • GF Value™: NT$707.93 vs. price of NT$20.55 (97.1% below fair value)
  • GF Score™: 42/100 with 3 warning signs

No single metric tells the full story. See the TPE:6885 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BRIM Biotechnology Business Description

Address Alley 30, Lane 358, Ruiguang Road, 8th Floor, No.1, Neihu District, Taipei, TWN, 11492
BRIM Biotechnology Inc is engaged in the research and development of new drug translation, genetic testing services, research and development services in natural and engineering sciences, and medical laboratory services. The Group has two reportable operating segments: BRIM's main business is new drug translational development services, and Compass's main business is gene sequencing and testing technology services. It generates the majority of its revenue from the BRIM segment. Geographically, it operates in Taiwan, Japan, and the USA. It generates the majority of its revenue from Taiwan.
42GF Score

Get the complete analysis for TPE:6885

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.55
Price
NT$707.93
GF Value